Is IMRN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for IMRN. It does not provide personalized investment advice.

IMRN (Immuron Limited American Depositary Shares) Stock Analysis - Financials

Immuron Limited American Depositary Shares (IMRN) is a publicly traded Healthcare sector company. As of May 21, 2026, IMRN trades at $0.99 with a market cap of $8.17M and a P/E ratio of 0.00. IMRN moved +0.00% today. Year to date, IMRN is +20.73%; over the trailing twelve months it is -38.51%. Its 52-week range spans $0.68 to $2.87. Rallies surfaces IMRN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are IMRN's key financials?

IMRN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. IMRN recently traded at $0.99. Market cap is $8.17M. P/E ratio is 0.00. Revenue is $0.

IMRN Key Metrics

Key financial metrics for IMRN
Metric	Value
Price	$0.99
Market Cap	$8.17M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$2.87
52-Week Low	$0.68
Volume	0
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

Latest IMRN News

Immuron’s Q3 Revenue Rises 16% to AUD 1.5M; Price Target Boosted to $4.00 — Apr 22, 2026
Immuron H1 FY2026 Revenue Up 5%, Net Loss Narrows and Cash Rises to AUD 10 Million — Mar 5, 2026

IMRN Analyst Consensus

IMRN analyst coverage data. Average price target: $0.00.

Common questions about IMRN

What are IMRN's key financials?: IMRN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. IMRN recently traded at $0.99. Market cap is $8.17M. P/E ratio is 0.00. Revenue is $0.
Is IMRN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for IMRN. It does not provide personalized investment advice.